Too much or not enough of a good thing? Cardiac glucolipotoxicity versus lipoprotection

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 1, 2011, Pages 2-5

  Taegtmeyer, Heinrich ^a   Stanley, William C ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; GLUCOSE; GLUCOSE 6 PHOSPHATE; HEXOSAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

CALCIUM METABOLISM; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FAT INTAKE; FATTY ACID METABOLISM; GLUCOSE METABOLISM; HEART FAILURE; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; INSULIN RESISTANCE; LIPOTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

CARBOHYDRATE METABOLISM; ENERGY METABOLISM; HEART; HUMANS; LIPID METABOLISM; METABOLIC SYNDROME X; MYOCARDIUM; OBESITY;

EID: 78650828098     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.09.014     Document Type: Note

References (26)

1. Kessler D. The end of overeating 2009, Rodale, New York.
2. http://thinkexist.com/quotation/what_nourishes_me_also_destroys_me/333853.html; Accessed July 29, 2009.
3. Brookheart R.T., Michel C.I., Schaffer J.E. As a matter of fat. Cell Metab 2009, 10:9-12.
4. Park S.Y., Cho Y.R., Finck B.N., Kim H.J., Higashimori T., Hong E.G., et al. Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver. Diabetes 2005, 54:2514-2524.
5. Sharma S., Adrogue J.V., Golfman L., Uray I., Lemm J., Youker K., et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004, 18:1692-1700.
6. Zhou Y.T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000, 97:1784-1789.
7. Wende A.R., Abel E.D. Lipotoxicity in the heart. Biochim Biophys Acta 1801, 311-319.
8. Copeland R.J., Bullen J.W., Hart G.W. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab 2008, 295:E17-E28.
9. Chatham J.C., Marchase R.B. The role of protein O-linked beta-N-acetylglucosamine in mediating cardiac stress responses. Biochim Biophys Acta 1800, 57-66.
10. Goodwin G.W., Cohen D.M., Taegtmeyer H. [5-3H]glucose overestimates glycolytic flux in isolated working rat heart: role of the pentose phosphate pathway. Am J Physiol Endocrinol Metab 2001, 280:E502-E508.
11. Young M.E., McNulty P., Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circulation 2002, 105:1861-1870.
12. Bing R.J., Siegel A., Ungar I., Gilbert M. Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism. Am J Med 1954, 16:504-515.
13. Hue L., Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 2009, 297:E578-E591.
14. Harmancey R., Wilson C.R., Taegtmeyer H. Adaptation and maladaptation of the heart in obesity. Hypertension 2008, 52:181-187.
15. Gross R.W., Han X. Shotgun lipidomics of neutral lipids as an enabling technology for elucidation of lipid-related diseases. Am J Physiol Endocrinol Metab 2009, 297:E297-E303.
16. Young M.E., Yan Z., Razeghi P., Cooksey R.C., Guthrie P.H., Stepkowski S.M., et al. Proposed regulation of gene expression by glucose in rodent heart. Gene Reg Systems Biol 2007, 1:251-262.
17. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N Engl J Med 2002, 347:305-313.
18. Leichman J.G., Wilson E.B., Scarborough T., Aguilar D., Miller C.C., Yu S., et al. Dramatic reversal of derangements in muscle metabolism and diastolic left ventricular function after bariatric surgery. Am J Med 2008, 121:966-973.
19. Wilson C.R., Tran M.K., Salazar K.L., Young M.E., Taegtmeyer H. Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. Biochem J 2007, 406:457-467.
20. Chess D.J., Stanley W.C. Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc Res 2008, 79:269-278.
21. Duda M.K., O'Shea K.M., Stanley W.C. Omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. Cardiovasc Res 2009, 84:33-41.
22. Hu F.B. Diet and cardiovascular disease prevention the need for a paradigm shift. J Am Coll Cardiol 2007, 50:22-24.
23. Lopaschuk G.D., Folmes C.D., Stanley W.C. Cardiac energy metabolism in obesity. Circ Res 2007, 101:335-347.
24. Szczepaniak L.S., Victor R.G., Orci L., Unger R.H. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 2007, 101:759-767.
25. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009, 53:1925-1932.
26. Virchow R. Cellular pathology as based upon physiological and pathological histology 1860, 325. John Churchill, London.